Board of Directors

Jeffrey W. Dunn serves as the Executive Chairman to our Board of Directors.  Mr. Dunn previously served as the President, Chief Executive Officer and Chairman of our Board of Directors from our inception in April 2008 until April 2021. Prior to joining SI BONE, Mr.

Laura A. Francis has served as our Chief Executive Officer and a Director on our Board since April 2021. As our Chief Financial Officer since May 2015 and Chief Operating Officer since July 2019, Ms. Francis played a fundamental role in bringing the company public in October 2018 and building the

Timothy (Ted) E. Davis, Jr. has served as a member of our board of directors since our inception in April 2008. Mr. Davis joined BioTissue Holdings Inc. (fka BioTissue,Inc.),  a market leader in regenerative therapies for treating the ocular surface and other surgical indications, as President and

John G. Freund, M.D. has served as a member of our board of directors since January 2013. Dr. Freund founded Skyline Ventures, a venture capital firm, in October 1997 and has served as a Managing Director of Skyline since then. Prior to joining Skyline, Dr.

Jeryl Lynn Hilleman is a member of the Board of Directors. In addition to SI-BONE, Inc., her current board positions include public companies Novocure (Nasdaq: NVCR), HilleVax (Nasdaq: HLVX) and Minerva Neurosciences (Nasdaq: NERV) as well as private companies Omada Health, where she is Chair of

Gregory K. Hinckley has served as a member of our board of directors since January 2011. In 2017, Mr. Hinckley retired as president of Mentor Graphics Corporation, a leader in electronic design automation, after serving in that role for nearly 20 years. Prior to Mentor, Mr.

Helen Loh has served as a member of our board of directors since April 2021. She has over 25 years of experience in brand and growth marketing at both Fortune 500 and early-stage technology companies. Currently, Ms. Loh is the Managing Director of Digital, Education and Client Marketing at Charles

Mika Nishimura has nearly 30 years of experience in medical technology, serving in a variety of operational and executive capacities. Ms. Nishimura is currently an Operational Partner with Gilde Healthcare Partners, a life-science focused venture fund.

Keith C. Valentine has served as a member of our board of directors since August 2015. Since July 2015, Mr. Valentine has also served as President, Chief Executive Officer and a member of the board of directors of SeaSpine Holdings Corporation, a global medical technology company.